UNSPSC 51184015: Tolazamide

This classification denotes an anti-diabetic agent with the molecular formula C14H21N3O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 9LT1BRO48Q, chemically known as 4-(p-tolylsulfonyl)-1,1-hexamethylenesemicarbazide but more generally known as tolazamide, which bears US NIH Compound Identifier 5503. European Medicines Agency schedules Tolazamide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11147MIG.

UNSPSC 51184015 Tolazamide is a Commodity code for procurement of tolazamide, an oral sulfonylurea antidiabetic medication used to manage type 2 diabetes. State and local governments procure tolazamide primarily through pharmacy benefit programs, medicaid formularies, and health plan coverage administered by state health departments, county health systems, municipal clinics, and regional public health authorities. The drug is purchased as a generic pharmaceutical in tablet form, typically in bulk quantities or through standing orders to support ongoing patient care at public health facilities, correctional institutions, and community health centers.

The provided source contains no records of recent state and local contract opportunities under this code, making current market activity indeterminate. Tolazamide procurement by state and local entities typically occurs through routine pharmaceutical supply contracts, group purchasing organization (GPO) participation, or medicaid reimbursement frameworks rather than through competitive solicitations posted as individual RFPs, RFQs, or ITBs. Without posted opportunities in the source, geographic concentration and issuing-body patterns cannot be characterized from recent activity.